Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 March 2020 | Story Xolisa Mnukwa | Photo Supplied
Student Governance dialogue session
The UFS Student Governance office aims to motivate engaged scholarship among students and academia, to act as a reservoir of excellence in governance, and shape an excellent landscape of leadership.

“I’m anticipating philosophical discussions that will unpack moral courage, ethics in leadership, and governance,” said UFS Manager for Student Governance, Buti Mnyakeni, in opening the Division of Student Affairs’ first annual Student Governance Leadership Series (SGL) at the University of the Free State (UFS). 

The Student Governance office intends to encourage engaged scholarship among students and academia to produce a broader landscape of equipped student leaders from the university. 

UFS Vice-Rector: Institutional Change, Student Affairs, and Community Engagement, Prof Puleng LenkaBula, joined by former SRC President, Phiwe Mathe, and student leaders Sam Masingi and Amanda Charles, provided rich and provoking contributions under the theme The concept of good governance. On the first day of the series, the discourse kicked off with problematising the concept, and further led to egocentrism, and Afrocentric modalities of governance. 

The panel also unpacked the exclusivity of governmental systems by discussing institutional and managerial culture, which according to them, results in detached knowledge and ways of thinking. 

Day two of the series focused on discussions around moral courage in the era of ethical decay. Attorney of the High Court and International Economic Law Lecturer at the UFS, Mmiselo Qumba; former Vice-President of the SRC, Bokang Fako; former president of the SRC, Richard Chemaly; and freelance writer, broadcaster, author, and communicator, Ace Moloi, engaged extensively on the influence of personal values on shared ethical standards as a vehicle that can lead to a socially just community and society.

The SGL series established a platform to encourage current and prospective student leaders to reflect, connect, and be innovative in their design thinking as leaders in their respective governance structures.

The Programme Director for the event, Adv Thanduxolo Nkala – an accredited mediator in commercial and court-annexed mediation – reflected on the dialogues as “rich and robust.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept